Track topics on Twitter Track topics that are important to you
The brokerage presently has a $338.00 price target on the biotechnology company's stock. Goldman Sachs Group, Inc. 's price objective points to a potential upside of 19.96% from the company's previous close.
Original Article: Biogen Inc.NEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...